Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Narazaciclib + Letrozole in Recurrent Metastatic Endometrial Cancer
NCT05705505Phase 2Recruiting
- Sponsor
- Traws Pharma, Inc.
- Start
- Mar 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of narazaciclib in endometrioid endometrial carcinoma (EEC), gynecologic malignancies, sponsored by Traws Pharma, Inc.. Started Mar 2023; status: recruiting.
02
Drugs
narazaciclib
03
Conditions
endometrioid endometrial carcinoma (EEC)gynecologic malignancies
Beyond the preview
Go deeper on NCT05705505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05705505.